Companies: 10,795·Total market cap: $144.5T
iTeos Therapeutics, Inc.

iTeos Therapeutics, Inc.

ITOSNASDAQHealthcare
$10.15
+$0.02(+0.20%)
Market Cap$448684810
P/E Ratio
52W High$17.63
52W Low$4.8
Overview

iTeos Therapeutics, Inc. (ITOS) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ITOS · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-4.74itos eps ttm · itos earnings per shareEarnings history
PE Ratio (TTM)itos pe ratio ttm · itos price to earningsPE Ratio deep dive
Revenue (TTM)0.00itos revenue ttm · itos annual revenueFull revenue history
Dividend YieldNo Dividenddoes itos pay dividends · itos dividend yieldDividend history
Shares Outstanding40.5Mitos shares outstanding · itos floatShares outstanding history
Next EarningsTBAitos earnings date · itos next earningsEarnings history

Financial Snapshot

Full Financials
FY 2024Revenue$35.0M▲ +177.89% YoY
202220232024
iteos therapeutics, inc. revenue · itos revenue 2024
FY 2024Net Income-$134.4M▼ 19.33% YoY
202220232024
iteos therapeutics, inc. net income · itos profit 2024
FY 2024EPS$-3.32▼ 5.40% YoY
202220232024
itos eps · iteos therapeutics, inc. earnings per share 2024
TTM:Revenue: $0.00Net Income: -$202.4MEPS: $-4.74View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold8 analystsis itos a buy · itos analyst rating
Strong Buy
0
Buy
3
Hold
5
Sell
0
Strong Sell
0
12-Month Price Target
$9.00Low
$10.15Current
$18.20Avg Target79.31% upside
$46.00High
itos price target · itos 12 month forecast

Total: 8 · Buy rate: 37.5%

The ITOS analyst consensus is Hold, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $18.20, representing +79.31% upside from the current price of $10.15.

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+2.01%
YTD+28.48%
1Y-0.59%
5Y-58.08%

About iTeos Therapeutics, Inc.

CEOMichel Detheux
IPO DateJul 24, 2020
Employees173
CountryUS

iTeos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm, concentrating on the discovery and advancement of immuno-oncology therapies for patients. The company's pipeline includes …

what is iteos therapeutics, inc. · itos stock overview · iteos therapeutics, inc. company profile · who is iteos therapeutics, inc. ceo · itos NASDAQ · iteos therapeutics, inc. headquarters · iteos therapeutics, inc. business segments

About Stock Overview & Key Data

iTeos Therapeutics, Inc. (ITOS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 24, 2020. As of the latest trading session, ITOS stock price is $10.15, with a market capitalization of $448.7M. The stock has returned -0.59% over the past 12 months and +28.48% year-to-date.

According to 8 Wall Street analysts, the consensus rating for iTeos Therapeutics, Inc. stock is Hold, with an average 12-month price target of $18.20. In fiscal year 2024, iTeos Therapeutics, Inc. reported revenue of $35.0M and net income of -$134.4M. For detailed data — including iTeos Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, iTeos Therapeutics, Inc. (ITOS) stock price is $10.15. The stock is traded on NASDAQ under the ticker symbol ITOS. The 52-week range is $4.80 – $17.63.

ITOS stock priceITOS quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice